Related references
Note: Only part of the references are listed.Chronic kidney disease in patients with non-alcoholic fatty liver disease: What the Hepatologist should know?
Stefania Kiapidou et al.
ANNALS OF HEPATOLOGY (2020)
Liver fibrosis by FibroScan® independently of established cardiovascular risk parameters associates with macrovascular and microvascular complications in patients with type 2 diabetes
Rosa Lombardi et al.
LIVER INTERNATIONAL (2020)
Association Between Fibrosis Stage and Outcomes of Patients with Non-Alcoholic Fatty Liver Disease: a Systematic Review and Meta-Analysis
Rod S. Taylor et al.
GASTROENTEROLOGY (2020)
Mechanisms of Fibrosis Development in NASH
Robert F. Schwabe et al.
GASTROENTEROLOGY (2020)
NAFLD as a driver of chronic kidney disease
Christopher D. Byrne et al.
JOURNAL OF HEPATOLOGY (2020)
Diverse Role of TGF-beta in Kidney Disease
Yue-Yu Gu et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Increasing metabolic co-morbidities are associated with higher risk of advanced fibrosis in nonalcoholic steatohepatitis
Robert J. Wong et al.
PLOS ONE (2019)
Nonalcoholic Fatty Liver Disease in Diabetes. Part I: Epidemiology and Diagnosis
Yong-ho Lee et al.
DIABETES & METABOLISM JOURNAL (2019)
Nonalcoholic fatty liver disease increases risk of incident chronic kidney disease: A systematic review and meta-analysis
Alessandro Mantovani et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2018)
Improvement in liver histology due to lifestyle modification is independently associated with improved kidney function in patients with non-alcoholic steatohepatitis
E. Vilar-Gomez et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
Development of chronic kidney disease in patients with non-alcoholic fatty liver disease: A cohort study
Dong Hyun Sinn et al.
JOURNAL OF HEPATOLOGY (2017)
Ultrasonographic fatty liver indicator detects mild steatosis and correlates with metabolic/histological parameters in various liver diseases
Stefano Ballestri et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2017)
Management of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes: A Call to Action
Fernando Bril et al.
DIABETES CARE (2017)
Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study
Raymond Kwok et al.
GUT (2016)
Presence of diabetes mellitus and steatosis is associated with liver stiffness in a general population: The Rotterdam study
Edith M. Koehler et al.
HEPATOLOGY (2016)
Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes
Zobair M. Younossi et al.
HEPATOLOGY (2016)
Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis
Giovanni Targher et al.
JOURNAL OF HEPATOLOGY (2016)
Nonalcoholic Fatty Liver Disease Is Independently Associated With an Increased Incidence of Chronic Kidney Disease in Patients With Type 1 Diabetes
Giovanni Targher et al.
DIABETES CARE (2014)
Hepatic steatosis and non-alcoholic fatty liver disease are not associated with decline in renal function in people with Type 2 diabetes
S. J. Jenks et al.
DIABETIC MEDICINE (2014)
Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
Yoshio Sumida et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Simple steatosis is a more relevant source of serum inflammatory markers than omental adipose tissue
Yan Li et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2014)
Association of Non-alcoholic Fatty Liver Disease with Chronic Kidney Disease: A Systematic Review and Meta-analysis
Giovanni Musso et al.
PLOS MEDICINE (2014)
Association between Nonalcoholic Liver Disease and Chronic Kidney Disease: An Ultrasound Analysis from NHANES 1988-1994
Jeffrey C. Sirota et al.
AMERICAN JOURNAL OF NEPHROLOGY (2012)
Increased prevalence of chronic kidney disease in patients with Type 1 diabetes and non-alcoholic fatty liver
G. Targher et al.
DIABETIC MEDICINE (2012)
Serum Fibroblast Growth Factor 21 Is Associated with Renal Function and Chronic Kidney Disease in Community-Dwelling Adults
Candace Crasto et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2012)
Ratio of Waist-to-Calf Circumference and Carotid Atherosclerosis in Korean Patients With Type 2 Diabetes
Soo-Kyung Kim et al.
DIABETES CARE (2011)
Nonalcoholic steatohepatitis and increased risk of chronic kidney disease
Kohichiroh Yasui et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2011)
Hepatic steatosis index: A simple screening tool reflecting nonalcoholic fatty liver disease
Jeong-Hoon Lee et al.
DIGESTIVE AND LIVER DISEASE (2010)
A New Equation to Estimate Glomerular Filtration Rate
Andrew S. Levey et al.
ANNALS OF INTERNAL MEDICINE (2009)
Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative/laser-treated retinopathy in type 2 diabetic patients
G. Targher et al.
DIABETOLOGIA (2008)